1 Szirmai I, Vastagh I, Szombathelyi E, et al. Strategic

infarcts of the thalamus in vascular dementia[J]. J

Neurol Sci, 2002, 203-204:91-97.

2 Seo SW, Hwa Lee B, Kim EJ, et al. Cl inical

significance of microbleeeds in subcortical vascular

dementia[J]. Stroke, 2007, 38:1949-1951.

3 American Psychiatric Association. Diagnostic and

Statistical Manual of Mental disorders[M]. 4th ed.

Washington DC:American Psychiatric Association,

1994.

4 Mckhann G, Drachman D, Folstein M, et al. Clinical

diagnosis of Alzheimer's disease:report of NINCDSADRDA

work group under the auspices of the

Department of Health and Human Services Task

Forces on Alzheimer's disease[J]. Neurology, 1984,

34:939-944.

5 Román GC, Tatemichi TK, Erkinjunt t i, et al.

Vascular dementia:diagnostic criteria for research

studies:report of the NINDS-AIREN International

Workshop[J]. Neurology, 1993, 43:250-260.

6 Fazekas F, Chawluk JB, Alavi A, et al. MR signal

abnormalities at 1.5 T in Alzheimer's dementia

and normal aging[J]. AJR Am J Roentgenol, 1987,

149:351-356.

7 Hachinski V, Iadecola C, Petersen RC, et al. National

Institute of Neurological Disorders and Stroke-

Canadian St roke Network vascula r cognit ive

impairment harmonization standards[J]. Stroke, 2006,

37:2220-2241.

8 Román GC, Erkinjuntti T, Wallin A, et al. Subcortical

ischaemic vascular dementia[J]. Lancet Neurol, 2002,

1:426-436.

9 Tanev K, Sablosky M, Vento J, et al. Structural and

functional neuroimaging methods in the diagnosis

of dementias:a retrospective chart and brain imaging

review[J]. Neurocase, 2012, 18:224-234.

10 Chutinet A, Rost NS. White matter disease as a

biomarker for long-term cerebrovascular disease and

dementia[J]. Curr Treat Options Cardiovasc Med,

2014, 16:292-303.

11 Launer LJ, Berger K, Breteler MM, et al. Regional

variability in the prevalence of cerebral white matter

lesions:An MRI study in 9 European countries

(CASCADE)[J]. Neuroepidemiology, 2006, 26:23-29.

12 Mendez MF, Ottowitz W, Brown CV, et al. Dementia

with leu koa r aiosis:clinical dif ferent iat ion by

temporoparietal hypometabolism on 18FDG-PET

imaging[J]. Dement Geriatr Cogn Disord, 1999,

10:518-525.

13 王瑞民, 田嘉禾, 贾建军, 等. 阿尔茨海默病与血管

性痴呆的18F-FDG PET脑显像[J]. 中华核医学杂志,

2004, 24:30-32.

14 Pascual B, Prieto E, Arbizu J, et al. Brain glucose

metabolism in vascular white matter disease with

dementia:differentiation from Alzheimer disease[J].

Stroke, 2010, 41:2889-2893.

15 Stenset V, Grambaite R, Reinvang I, et al. Diaschisis

after thalamic stroke:a comparison of metabolic

and structural changes in a patient with amnesic syndrome[J]. Acta Neurol Scand Suppl, 2007, 187:68-

71.

16 Alexander GE, DeLong MR, Strick PL. Parallel

organization of functionally segregated circuits

linking basal ganglia and cortex[J]. Ann Rev Neurosci,

1990, 13:266-271.

17 Chui HC. Subcortical ischemic vascular dementia[J].

Neurol Clin, 2007, 25:717-740.

18 La nd au SM, Ha r vey D, Ma d i son CM, e t a l .

Associations between cognitive, functional, and

FDG-PET measures of decline in AD and MCI[J].

Neurobiol Aging, 2011, 32:1207-1218.

19 Tan YL, Ng A, Kandiah N. Frontotemporal dementia

in Southeast Asia:A comparative study[J]. Dement

Geriatr Cogn Dis Extra, 2013, 3:1-9.

20 Kantarci K, Lowe VJ, Boeve BF, et al. Multimodality

imaging characteristics of dementia with Lewy

bodies[J]. Neurobiol Aging, 2012, 33:2091-2105.

21 Dukart J, Mueller K, Villringer A, et al. Relationship

between imaging biomarkers, age, progression

and symptom severity in Alzheimer's disease[J].

Neuroimage Clin, 2013, 3:84-94.

22 Ewers M, Brendel M, Rizk-Jackson A, et al. Reduced

FDG-PET brain metabolism and executive function

predict clinical progression in elderly healthy

subjects[J]. Neuroimage Clin, 2013, 4:45-52.

23 Jellinger KA. Alzheimer disease and cerebrovascular,

pathology:an update[J]. J Neurol Transm, 2002,

109:813-836.

24 Jellinger KA, Attems J. Prevalence and pathogenic

role of cerebrovascular lesions in Alzheimer's

disease[J]. J Neurol Sci, 2005, 229-230:37-41.